It has recently been reported that Parkinson's disease (PD) is preceded and accompanied by daytime sleep attacks, nocturnal insomnia, REM sleep behaviour disorder, hallucinations and depression, symptoms which are frequently as troublesome as the motor symptoms of PD. All these symptoms are present in narcolepsy, which is linked to a selective loss of hypocretin (Hcrt) neurons. In this study, the Hcrt system was examined to determine if Hcrt cells are damaged in PD. The hypothalamus of 11 PD (mean age 79 ± 4) and 5 normal (mean age 77 ± 3) brains was examined. Sections were immunostained for Hcrt-1, melanin concentrating hormone (MCH) and alpha synuclein and glial fibrillary acidic protein (GFAP). The substantia nigra of 10 PD brains and 7 normal brains were used for a study of neuromelanin pigmented cell loss. The severity of PD was assessed using the Hoehn and Yahr scale and the level of neuropathology was assessed using the Braak staging criteria. Cell number, distribution and size were determined with stereologic techniques on a one in eight series.
We found an increasing loss of hypocretin cells with disease progression. Similarly, there was an increased loss of MCH cells with disease severity. Hcrt and MCH cells were lost throughout the anterior to posterior extent of their hypothalamic distributions. The percentage loss of Hcrt cells was minimal in stage I (23%) and was maximal in stage V (62%). Similarly, the percentage loss of MCH cells was lowest in stage I (12%) and was highest in stage V (74%). There was a significant increase (P = 0.0006,t = 4.25, df = 15) in the size of neuromelanin containing cells in PD patients, but no difference in the size of surviving Hcrt (P = 0.18,t = 1.39, df = 14) and MCH (P = 0.28,t = 1.39, df = 14) cells relative to controls.
In summary, we found that PD is characterized by a massive loss of Hcrt neurons. Thus, the loss of Hcrt cells may be a cause of the narcolepsy-like symptoms of PD and may be ameliorated by treatments aimed at reversing the Hcrt deficit. We also saw a substantial loss of hypothalamic MCH neurons. The losses of Hcrt and MCH neurons are significantly correlated with the clinical stage of PD, not disease duration, whereas the loss of neuromelanin cells is significantly correlated only with disease duration. The significant correlations that we found between the loss of Hcrt and MCH neurons and the clinical stage of PD, in contrast to the lack of a relationship of similar strength between loss of neuromelanin containing cells and the clinical symptoms of PD, suggests a previously unappreciated relationship between hypothalamic dysfunction and the time course of the overall clinical picture of PD.
Access to content on Oxford Academic is often provided through institutional subscriptions and purchases. If you are a member of an institution with an active account, you may be able to access content in one of the following ways:
Typically, access is provided across an institutional network to a range of IP addresses. This authentication occurs automatically, and it is not possible to sign out of an IP authenticated account.
Choose this option to get remote access when outside your institution. Shibboleth/Open Athens technology is used to provide single sign-on between your institution’s website and Oxford Academic.
If your institution is not listed or you cannot sign in to your institution’s website, please contact your librarian or administrator.
Enter your library card number to sign in. If you cannot sign in, please contact your librarian.
Society member access to a journal is achieved in one of the following ways:
Many societies offer single sign-on between the society website and Oxford Academic. If you see ‘Sign in through society site’ in the sign in pane within a journal:
If you do not have a society account or have forgotten your username or password, please contact your society.
Some societies use Oxford Academic personal accounts to provide access to their members. See below.
A personal account can be used to get email alerts, save searches, purchase content, and activate subscriptions.
Some societies use Oxford Academic personal accounts to provide access to their members.
Click the account icon in the top right to:
Oxford Academic is home to a wide variety of products. The institutional subscription may not cover the content that you are trying to access. If you believe you should have access to that content, please contact your librarian.
For librarians and administrators, your personal account also provides access to institutional account management. Here you will find options to view and activate subscriptions, manage institutional settings and access options, access usage statistics, and more.
Month: | Total Views: |
---|---|
December 2016 | 2 |
January 2017 | 16 |
February 2017 | 19 |
March 2017 | 29 |
April 2017 | 25 |
May 2017 | 24 |
June 2017 | 10 |
July 2017 | 20 |
August 2017 | 10 |
September 2017 | 19 |
October 2017 | 16 |
November 2017 | 25 |
December 2017 | 44 |
January 2018 | 40 |
February 2018 | 40 |
March 2018 | 75 |
April 2018 | 46 |
May 2018 | 49 |
June 2018 | 52 |
July 2018 | 48 |
August 2018 | 51 |
September 2018 | 29 |
October 2018 | 43 |
November 2018 | 57 |
December 2018 | 43 |
January 2019 | 35 |
February 2019 | 58 |
March 2019 | 77 |
April 2019 | 67 |
May 2019 | 52 |
June 2019 | 53 |
July 2019 | 60 |
August 2019 | 28 |
September 2019 | 54 |
October 2019 | 59 |
November 2019 | 25 |
December 2019 | 59 |
January 2020 | 54 |
February 2020 | 49 |
March 2020 | 75 |
April 2020 | 71 |
May 2020 | 41 |
June 2020 | 49 |
July 2020 | 40 |
August 2020 | 59 |
September 2020 | 78 |
October 2020 | 33 |
November 2020 | 38 |
December 2020 | 40 |
January 2021 | 54 |
February 2021 | 31 |
March 2021 | 68 |
April 2021 | 56 |
May 2021 | 56 |
June 2021 | 49 |
July 2021 | 58 |
August 2021 | 49 |
September 2021 | 62 |
October 2021 | 43 |
November 2021 | 68 |
December 2021 | 29 |
January 2022 | 45 |
February 2022 | 34 |
March 2022 | 28 |
April 2022 | 39 |
May 2022 | 45 |
June 2022 | 37 |
July 2022 | 47 |
August 2022 | 51 |
September 2022 | 71 |
October 2022 | 60 |
November 2022 | 34 |
December 2022 | 51 |
January 2023 | 88 |
February 2023 | 70 |
March 2023 | 61 |
April 2023 | 82 |
May 2023 | 119 |
June 2023 | 64 |
July 2023 | 65 |
August 2023 | 63 |
September 2023 | 46 |
October 2023 | 63 |
November 2023 | 55 |
December 2023 | 74 |
January 2024 | 70 |
February 2024 | 50 |
March 2024 | 54 |
April 2024 | 56 |
May 2024 | 78 |
June 2024 | 59 |
July 2024 | 27 |
August 2024 | 36 |
September 2024 | 30 |
October 2024 | 17 |
November 2024 | 19 |
December 2024 | 7 |
January 2025 | 22 |
February 2025 | 19 |
March 2025 | 29 |
Oxford University Press is a department of the University of Oxford. It furthers the University's objective of excellence in research, scholarship, and education by publishing worldwide
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.